PharmaVentures and PharmaTelevision are delighted to be Media Partners at the World Stem Cells & Regenerative Medicine Congress 2015.
Dr Adrian Dawkes will be recording a series of interviews for PharmaTelevision with key people attending what looks to be a very exciting event.
A decade on and still strong: London celebrates the 10th anniversary of World Stem Cells & Regenerative Medicine Congress.
2005. What a year!
London was overjoyed at being elected as host city for the 2012 Olympics, but also devastated by the July 7th terror attacks. The death of Pope John Paul II, that same year, marked the end of an era in the life of the Roman-Catholic Church whilst in Germany, Angela Merkel becomes their first female Chancellor. 2005 also played host to Hurricane Katrina in the United States when it flooded New Orleans, the launch of YouTube and it is where Terrapinn’s stem cell story starts.
A decade later and it is a delight to be celebrating the 10th anniversary of an event that was key to the foundations of this medical revolution.
“10 years ago when we launched the World Stem Cells Congress, the stem cells sector was one of scientific interest. Focussing on the challenges of how to transform the cells, this conference and exhibition was quite small and the topic area quite niche. Attracting only around 80 people, word of the industry’s potential had not yet reached the masses”, says Derek Cavanagh, Project Manager of World Stem Cells & Regenerative Medicine Congress 2015. He goes on to speak about how in about 2010 the sector underwent an important transition. Key industrial players as well as leading pharma companies had come to realise the commercial opportunities with stem cells, which would change the sector moving forward.
This in turn was when the event would shift in focus from solely science to incorporate the commercial aspects as well. Both translational medicine and regenerative medicine were added to the conference programme, and an emphasis on achieving market access was enabling successful commercial development within the industry. As industry challenges shifted towards lack of investment and scaling up manufacturing and distribution, discussions moved on to the new business models that were coming into practice as the stem cell sector developed and moved away from traditional pharma models, which would inevitably catapult the industry to where we are now.
What is now the World Stem Cells & Regenerative Medicine Congress is proud to be welcoming an audience of around 600 attendees to London this May. “This year we will be introducing additional content on tissue engineering and organ regeneration as well as the collocated Investor Forum and Cord Blood World Europe. Delegates will be able to hear and learn from over 70 speakers across the 3 days as well as partake in hundreds of meetings on-site as collaborations become key to commercial success of the industry” explains Hannah Yates, Conference Manager, World Stem Cells & Regenerative Medicine Congress 2015.
With a large volume of business generated over the years at this event, key industry supporters such as Cell Therapy Catapult, GE Healthcare and Lonza, and leading keynote presentations from the likes of Chris Mason, Perry Karsen, Keith Thompson, Michael May and Susan Solomon, World Stem Cells & Regenerative Medicine Congress is where the cell therapy and regenerative medicine sectors come to do business.
For more information, see the brochure at terrapinn.com /StemCellsBrochure
10th Annual World Stem Cells & Regenerative Medicine Congress 2015
20 – 22 May 2015
Business Design Centre, London, UK